<b>What Is Virotherapy</b><br />Reprogramming viruses in order to cure illness is an example of virotherapy, which is a kind of treatment that makes use of biotechnology to turn viruses into therapeutic agents. Anti-cancer oncolytic viruses, viral vectors for gene therapy, and viral immunotherapy are the three primary subspecialties that fall under the umbrella term &quot;virotherapy.&quot; Gene overexpression, gene knockout, and suicide gene delivery are the three distinct approaches that are used by these branches throughout the therapeutic process. Gene overexpression results in the addition of genetic sequences that make up for insufficient or nonexistent amounts of essential gene expression. Gene silencing or expression reduction may be achieved by gene deletion by using RNA-based techniques. The delivery of suicide genes involves the introduction of genetic sequences that trigger an apoptotic response in cells; this is often done in order to eliminate malignant growths. In a somewhat different setting, the term &quot;virotherapy&quot; may also refer to the use of viruses to cure certain medical problems by eliminating infections. This is one definition of the term.<br /><br /><b>How You Will Benefit</b><br />(I) Insights, and validations about the following topics:<br />Chapter 1: Virotherapy<br />Chapter 2: Gene therapy<br />Chapter 3: Immunotherapy<br />Chapter 4: Cancer vaccine<br />Chapter 5: Chimeric antigen receptor T cell<br />Chapter 6: Cancer immunotherapy<br />Chapter 7: Oncolytic virus<br />Chapter 8: Viral vector<br />Chapter 9: Murine respirovirus<br />Chapter 10: Oncolytics Biotech<br />Chapter 11: Pelareorep<br />Chapter 12: Molecular oncology<br />Chapter 13: Pexastimogene devacirepvec<br />Chapter 14: Talimogene laherparepvec<br />Chapter 15: Oncolytic herpes virus<br />Chapter 16: Oncolytic adenovirus<br />Chapter 17: Measles virus encoding the human thyroidal sodium iodide symporter<br />Chapter 18: Timeline of cancer treatment development<br />Chapter 19: Julianna Lisziewicz<br />Chapter 20: Oncolytic AAV<br />Chapter 21: Viral vector vaccine<br />(II) Answering the public top questions about virotherapy.<br />(III) Real world examples for the usage of virotherapy in many fields.<br />(IV) 17 appendices to explain, briefly, 266 emerging technologies in each industry to have 360-degree full understanding of virotherapy&#39; technologies.<br /><br /><b>Who This Book Is For</b><br />Professionals, undergraduate and graduate students, enthusiasts, hobbyists, and those who want to go beyond basic knowledge or information for any kind of virotherapy.